← Open Payments lookup

WEIQIN XU: Open Payments

NPI 1154839058 · ROSEMEAD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$8,384 in 287 payments from 50 companies in 2025. Trend: 2023 $9,298 · 2024 $10,464 · 2025 $8,384

Food & beverage: $7,057Long term medical supply or device loan: $1,000Education: $327
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation26$1,350
Janssen Biotech, Inc.35$1,098
AstraZeneca Pharmaceuticals LP29$1,002
BeOne Medicines USA, Inc.10$346
Incyte Corporation16$275
PFIZER INC.15$274
Bayer Healthcare Pharmaceuticals Inc.9$271
Merck Sharp & Dohme LLC10$235
ABBVIE INC.8$230
E.R. Squibb & Sons, L.L.C.6$228

Products named: KISQALI, RYBREVANT, ERLEADA, BRUKINSA, Nubeqa, ENHERTU, IMFINZI, DARZALEX.

Industry payments across CA — which companies pay providers there.